Recce Pharmaceuticals Ltd
Company Profile
Business description
Recce Pharmaceuticals Ltd is an Australia-based globally-focused biotechnology company engaged in the development and commercialization of a new class of antibiotics. It operates in only one business segment being research and development of pharmaceutical drugs. The firm operates in three geographic segments being Australia, the United Kingdom, and the United States of America, of which the majority of the revenue comes from Australia. The company offers antibiotic drugs to treat the diseases caused by various bacterias namely Sepsis, Helicobacter Pylori, Escherichia coli, Pseudomonas aeruginosa, and others.
Contact
180 George Street
Level 23
Salesforce Tower
Sydney NSW 2000
AUST: +61 292562505
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2024
Employees
Stocks News & Analysis
stocks
Any benefit from acquisition of ASX listed company’s business units?
stocks
3 ASX shares to avoid
stocks
How to find companies that can grow forever
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,035.60 | 41.10 | -0.51% |
| CAC 40 | 8,131.41 | 55.73 | 0.69% |
| DAX 40 | 18,498.38 | 68.33 | 0.37% |
| Dow JONES (US) | 39,056.39 | 172.13 | 0.44% |
| FTSE 100 | 8,354.05 | 40.38 | 0.49% |
| HKSE | 18,313.86 | 165.51 | -0.90% |
| NASDAQ | 16,302.76 | 29.80 | -0.18% |
| Nikkei 225 | 38,262.33 | 59.96 | 0.16% |
| NZX 50 Index | 11,728.85 | 54.04 | -0.46% |
| S&P 500 | 5,187.67 | 0.03 | -0.00% |
| S&P/ASX 200 | 7,762.60 | 41.90 | -0.54% |
| SSE Composite Index | 3,128.48 | 19.26 | -0.61% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Imugene Ltd IMU | 0.07 | 0.00 | -5.33% |
| Sayona Mining Ltd SYA | 0.04 | 0.00 | 0.00% |
| Westpac Banking Corp WBC | 26.54 | 1.35 | -4.84% |
| Cleanaway Waste Management Ltd CWY | 2.69 | 0.04 | -1.29% |
| Strike Energy Ltd STX | 0.24 | 0.02 | 6.82% |
| Botanix Pharmaceuticals Ltd BOT | 0.28 | 0.01 | -3.45% |
| Mesoblast Ltd MSB | 1.09 | 0.04 | -3.54% |
| Red 5 Ltd RED | 0.45 | 0.01 | -1.11% |
| Carnarvon Energy Ltd CVN | 0.21 | 0.01 | 5.13% |
| Pilbara Minerals Ltd PLS | 4.09 | 0.09 | -2.15% |